FUS for pancreatic cancer

Project Name: FUS for pancreatic cancer
Status: Active
Primary Site: Institute of Cancer Research
Sponsor Organization: Focused Ultrasound Foundation
Funded Date: Feb 06, 2020
Funding Period: Feb 06, 2020 - Feb 06, 2021
Funding Program: Immunotherapy
Category: Pre-Clinical
Amount Awarded: $70,864.08

Abstract

Advances in immunotherapy have revolutionized the treatment of cancer, providing cures to patients with previously lethal disease. Sadly, clinical trials of currently established immunotherapies have not provided therapeutic benefit to pancreatic cancer patients. For this reason, alternative immunotherapeutic approaches are needed. Oncolytic viruses represent one form of immunotherapy. These viruses infect and kill cancer cells while leaving normal tissue unharmed. We and others have tested their ability to treat some forms of cancer, including brain and skin tumours, but their use in pancreatic cancer has not been fully validated yet, partly due to the low infection rates they exhibit.

Contact Roles

Reports

No reports found.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email
Whitelist Instructions